Ronald E. Blaylock - 23 Apr 2026 Form 4 Insider Report for PFIZER INC (PFE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Apr 2026, 18:37:58 UTC
Prior SEC filing
13 Jun 2025
Next SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shanice A. Reid, by power of atty., for Ronald E. Blaylock

Key filing fact

Ronald E. Blaylock filed Form 4 for PFIZER INC (PFE) on 27 Apr 2026.

Key facts

  • This page summarizes Ronald E. Blaylock's Form 4 filing for PFIZER INC (PFE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 Apr 2026, 18:37.

Change

  • Previous filing in this sequence was filed on 13 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001214686 Primary reporting owner

BLAYLOCK RONALD E

Relationship
Director
Address
66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK
Signature
/s/ Shanice A. Reid, by power of atty., for Ronald E. Blaylock
Signature date
27 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Phantom Stock Units

Award

Transaction value
Shares
+7,687
Change %
+10%
Price
$26.67*
Shares after
84,013
Date
23 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,687
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each unit represents one phantom share of common stock.

Footnote F2

Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

Footnote F3

These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .